P-glycoprotein – a marker of cancer-cell behavior
ATP Binding Cassette Transporter, Subfamily B, Member 1
Drug Resistance, Multiple
Drug Resistance, Neoplasm
Resistance to a broad array of cytotoxic drugs – multidrug resistance – is thought to be a major reason chemotherapy fails to cure most cancers. Multidrug resistance has been studied intensively since the human MDR1 gene was identified almost 10 years ago.1 Increased levels of the MDR1 product, called P-glycoprotein, are often associated in vitro with reduced intracellular concentrations of several anticancer drugs derived from plants, such as anthracyclines (e.g., doxorubicin), epipodophyllotoxins (e.g., etoposide), vinca alkaloids (e.g., vincristine), dactinomycin, and paclitaxel. When cells are grown in increasing concentrations of one of these cytotoxic drugs, populations of cells that overexpress the. © 1995, Massachusetts Medical Society. All rights reserved.
Digital Object Identifier (DOI)
Additional Document Info
has global citation frequency